期刊档案

Biomarkers in Medicine

— · ISSN 1752-0363 · 医学-医学:研究与实验

数据可追溯 · letpub-v6 · 更新于 2026-08-24
影响指标2.37
h-index37
平均审稿速度网友分享经验:较慢,6-12周
平均录用比例网友分享经验:一般

期刊简介

研究范围与定位

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

结构化分区

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 2 个学科记录

Top:否综述:N/A
类别学科分区
大类医学4区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL4区

期刊分区表( 2025年3月升级版)

2025-03 · 2 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL4区

期刊分区表( 2023年12月旧的升级版)

2023-12 · 2 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL4区

期刊档案

出版与身份

期刊ISSN
1752-0363
E-ISSN
1752-0371
是否OA开放访问
No
通讯方式
FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
出版商
Future Medicine Ltd.
出版国家或地区
ENGLAND
出版语言
English
出版周期
Bimonthly
出版年份
2007

期刊档案

研究范围

期刊简介
Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
涉及的研究方向
医学-医学:研究与实验

期刊档案

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子
截止2026年5月06日:2.37
2025-2026自引率
4.8%点击查看自引率趋势图
五年IF(数据来源于网友提供)
1.897数据由网友[DarkEagle64]收集提供
h-index
37
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名3.200.5820.615学科分区排名百分位大类:Medicine小类:Biochemistry (medical)Q239 / 78 大类:Medicine小类:Clinical BiochemistryQ380 / 124 大类:Medicine小类:Drug DiscoveryQ3111 / 161
年文章数
130点击查看年文章数趋势图
Gold OA文章占比
4.08%
研究类文章占比:文章 ÷(文章 + 综述)
82.31%

期刊档案

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
SCI期刊收录coverage
Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)
PubMed Central (PMC)链接
访问官方页面 ↗

期刊档案

投稿与评审

期刊官方网站
访问官方页面 ↗
期刊投稿网址
访问官方页面 ↗
平均审稿速度
网友分享经验:较慢,6-12周
平均录用比例
网友分享经验:一般

来源与统计口径

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。